Immunophotonics

Immunophotonics

 

Immunophotonics  is a biotech company whose main objective is to develop and introduce inCVAX, a therapeutic cancer vaccine for the treatment of solid tumor cancers. First-in-man offshore trials yielded promising results, with tumor shrinkage of both treated local tumors and distant metastases, leading in some cases to a complete resolution of all tumors. inCVAX is practical to administer and has shown no evidence of toxicity.